Navigation Links
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Date:11/24/2008

s clearly support naproxcinod's non-detrimental blood pressure profile

The blood pressure data for naproxcinod 750 mg bid were consistent with those obtained in the 301 and 302 studies. Blood pressure was measured using standardized and controlled office blood pressure measurements (OBPM) at baseline and at weeks 2, 6 and 13 (see NOTE). At all time points, the patients treated with naproxcinod 750 mg bid showed a very similar blood pressure profile to those on placebo. In addition, naproxcinod 750 mg bid showed a clear reduction in systolic and diastolic blood pressure (SBP and DBP) compared to naproxen 500 mg bid at all time points. No stand alone statistical analysis of the blood pressure data from the 303 study was pre-specified.

As planned, NicOx will pool the blood pressure data from the three phase 3 studies (301, 302 and 303) according to a prospectively designed protocol that has been submitted to the FDA. The Company will disclose the top-line results of the pre-specified statistical analysis on the pooled data in the coming weeks.

Naproxcinod and placebo show the same gastrointestinal (GI) adverse event rate

Naproxcinod 750 mg bid showed good overall safety and tolerability. The percentage of patients who experienced one or more GI adverse events was the same for placebo and naproxcinod 750 mg bid at 15.5%, compared to 19.2% for naproxen 500 mg bid. In terms of the percentage of patients who experienced at least one adverse event overall, this was lower for naproxcinod 750 mg than naproxen 500 mg bid. There was not a single serious cardiovascular or serious GI adverse event in the naproxcinod arm during the 13 weeks of the 303 study, in contrast to the placebo and naproxen 500 mg bid arms.

Pascal Pfister MD, Chief Scientific Officer and Head of Research and Development at NicOx, commented: "We believe these are extremely good results, with naproxcinod demonstrating cl
'/>"/>

SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

13611

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
4. CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
5. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
6. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
7. NewCardio Announces Positive Results From Third Clinical Validation Study
8. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
9. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
10. NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
11. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 Research ... the addition of the "Arthroscopy Devices ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of ... the world market for Arthroscopy Devices. The ... impacting the market for these products. , ...
(Date:5/21/2015)... 2015  Cardica, Inc. (Nasdaq: CRDC ) today announced ... , the company,s vice president of operations, was granted an ... at a per share exercise price of $0.43, the closing ... granted pursuant to Cardica, Inc.,s Inducement Plan, which was approved ... Rule 5653(c)(4) of the Nasdaq Global Market for equity grants ...
(Date:5/21/2015)... May 21, 2015 The Pharmaceutical Care ... the Medicare Part D offsets included in the ... "If the 21st Century Cures initiative can ... premier health program – Medicare – then its ... down the road. "Leveraging payments to ...
Breaking Medicine Technology:Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Cardica Announces New Employment Inducement Grant 2
... 22, 2011 Prasco Laboratories, the Authorized Generics company, ... Shionogi Inc . Under the terms of the ... Nitrofurantoin Oral Suspension, the Authorized Generic version of Furadantin® Oral ... U.S. under the Prasco label. "Prasco is ...
... ("MGT", "we", or "the Company") (AMEX: MGT ), a ... following update on recent developments at the Company and its majority-owned ... a summary of its recently filed financial results (via SEC Form ... 2011. Highlights: On ...
Cached Medicine Technology:Prasco® Launches Authorized Generic with Shionogi Inc. 2MGT Capital Investments, Inc. Provides Update on Recent Developments 2MGT Capital Investments, Inc. Provides Update on Recent Developments 3MGT Capital Investments, Inc. Provides Update on Recent Developments 4MGT Capital Investments, Inc. Provides Update on Recent Developments 5MGT Capital Investments, Inc. Provides Update on Recent Developments 6
(Date:5/22/2015)... Mountain Point Medical Center, a campus of Jordan Valley Medical ... 29, 2015 at 11 a.m., followed by a community celebration ... set to officially open on June 1, 2015, is located ... “The opening of Mountain Point Medical Center is an exciting ... Kent Loosle, CEO of Mountain Point Medical Center. “Mountain Point ...
(Date:5/22/2015)... NS (PRWEB) May 22, 2015 Following ... a sale agreement with US-based health brand Nature’s Way, ... Skin brand. Retention of Ascenta Skin is an integral ... is excited about this opportunity to further develop Ascenta ... , Ascenta Skin is a breakthrough, anti-aging skincare ...
(Date:5/22/2015)... Island, NY (PRWEB) May 22, 2015 ... announces that June 17, 2015, the Annual One Day ... place. Since 2007, Hands On HCMT offers drastically reduced certificates ... therapists and estheticians have enough sessions, through what used to ... it is wonderful for the community as well. This once ...
(Date:5/22/2015)... 22, 2015 Carnegie Science Center ... announced a new partnership to develop BodyTech, a dynamic, ... The initiative includes a new exhibit at the Science ... theater, and a new traveling science show, Anatomy Adventure, ... 2015. , Designed to explore a wide range ...
(Date:5/22/2015)... According to a new Aegis Living Study ... as likely to worry about what will happen to their ... Boomers, 69% Silent Generation), which may help explain why nearly ... aging, particularly Millennials (47%), Gen X’ers (51%), and Boomers (43%). ... 2015 among more than 2,000 U.S. adults ages 18+. ...
Breaking Medicine News(10 mins):Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3
... dangerous characteristics of cancer is its ability to metastasize, or ... major need for better tests to detect cells that break ... the body. Effective identification of these cells, referred to ... improve quality of life for many cancer patients. A commentary ...
... 16, 2010 The AIUM is pleased to ... AIUM to endorse the recent AIUM Training Guidelines ... guidelines allow for a several practitioners, including physicians, ... ultrasound examinations, marking significant promise for the future ...
... ... Healthcare, 89 percent of physicians agree that patients receiving negligent treatment deserve fair compensation. ... Alpharetta, GA (Vocus) March 16, ... of physicians agree that patients receiving negligent treatment deserve fair compensation. , , , , ...
... Many with severe peripheral arterial disease can avoid amputation, ... When angioplasty fails, patients with severe peripheral arterial disease ... placed in the blocked artery below the knee might ... limb ischemia, the most severe form of peripheral arterial ...
... taking Plavix before surgery died soon after than those ... (HealthDay News) -- In a trial comparing two anti-clotting ... less likely to die than those given Plavix, researchers ... forming clots, but Plavix, the more popular drug, has ...
... President and CEO Dr. Richard Merkin , was featured on several segments throughout the day on Fox National News and Fox Business Channel discussing current healthcare payment structures ... ... ... ...
Cached Medicine News:Health News:Revisiting the need to detect circulating tumor cells 2Health News:Unprecedented AIUM training guidelines speak to future of musculoskeletal ultrasound 2Health News:Recent Survey Reveals That Physicians Overwhelmingly Support Patient Compensation When Harmed 2Health News:Recent Survey Reveals That Physicians Overwhelmingly Support Patient Compensation When Harmed 3Health News:Stenting May Save Legs 2Health News:Stenting May Save Legs 3Health News:Newer Blood Thinner Beats Plavix for Bypass Patients 2Health News:Newer Blood Thinner Beats Plavix for Bypass Patients 3Health News:Lakeside Medical Group, Heritage Provider Network, CEO Dr. Richard Merkin, Featured on Several Segments of Fox National News and Fox Business Channel on Current Healthcare Payment Structures to Physicians 2Health News:Lakeside Medical Group, Heritage Provider Network, CEO Dr. Richard Merkin, Featured on Several Segments of Fox National News and Fox Business Channel on Current Healthcare Payment Structures to Physicians 3
... Post Operative Pin® Knee Brace (DxHDDLP) has a ... drop lock lever and laminate liner. The precision ... brace from migrating on the leg during ambulation. ... that controls flexion and extension in 5° increments ...
... Neuroprene™ soft supports are a convenient, ... proprioceptive taping for common orthopedic conditions/instabilities. ... provide specific compression and lateral to ... (proprioceptors) in the skin and soft ...
... The Drytex Adjustable Patella Donut ... a unique nylon core and polyester ... airflow. A trimable full-circumference donut provides ... who have neoprene based allergies or ...
... for total knees, meniscus repairs, regenerative chondroplasty, ... TROM gives easy-to-use range of motion control ... Rehab TROM can be used as a ... purchased separately be used with the TROM ...
Medicine Products: